IDEAYA Biosciences (IDYA) Prices 6.67M Share Common Offering at $15/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St slips on rising bond yields; Walmart results weigh
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Ideaya Biosciences (IDYA) PT Raised to $22 at H.C. Wainwright
June 17, 2020 6:05 AM EDTH.C. Wainwright analyst Edward White raised the price target on Ideaya Biosciences (NASDAQ: IDYA) to $22.00 (from $13.00) while maintaining a Buy rating.... More
IDEAYA Biosciences (IDYA) Announces $60M Proposed Public Offering of Common Stock
June 16, 2020 4:01 PM EDTIDEAYA Biosciences, Inc. (Nasdaq: IDYA) today announced that it intends to offer and sell up to $60 million of shares of its common stock in an underwritten public offering. In addition, IDEAYA intends to grant the underwriters a 30-day option to purchase up to $9 million of shares of its common stock. The offering is subject to market and other conditions, and there can be no... More
Ideaya Biosciences (IDYA) PT Raised to $25 at Oppenheimer
June 16, 2020 11:23 AM EDTOppenheimer analyst Kevin DeGeeter raised the price target on Ideaya Biosciences (NASDAQ: IDYA) to $25.00 (from $17.00) while maintaining a Outperform rating.
... MoreIDEAYA Biosciences (IDYA) Gains 60% on GSK Deal
June 16, 2020 9:31 AM EDTIDEAYA Biosciences, Inc. (Nasdaq: IDYA) gains 60% as the company GlaxoSmithKline plc (NYSE: GSK) announce a strategic partnership in Synthetic Lethality, an emerging field in Oncology.
... MorePre-Open Stock Movers 06/16: (IDYA) (IQ) (HEAR) Higher; (IZEA) (CLDX) (CHK) Lower (more...)
June 16, 2020 9:29 AM EDTToday'sPre-Open Stock Movers
IDEAYA Biosciences, Inc. (Nasdaq: IDYA) 78.3% HIGHER; IDEAYA and GlaxoSmithKline plc (GSK) announce a strategic partnership in Synthetic Lethality, an emerging field in Oncology.
iQIYI (NASDAQ: IQ) 40% HIGHER; Tencent aims to become biggest shareholder of video streaming rival iQIYI - Reuters
Turtle Beach Corporation (NASDAQ: HEAR) 28.7% HIGHER; has increased its sales outlook for the quarter ending June 30, 2020 based on continued strong demand and significant... More
IDEAYA Biosciences (IDYA), GSK (GSK) Announce Broad Partnership in Synthetic Lethality
June 16, 2020 6:26 AM EDTIDEAYA Biosciences, Inc. (Nasdaq: IDYA) and GlaxoSmithKline plc (GSK) announce a strategic partnership in Synthetic Lethality, an emerging field in Oncology.
The strategic partnership includes IDEAYA's Synthetic Lethality programs MAT2A, Pol Theta, and Werner Helicase programs, which are projected to reach clinical trials within the next three years. IDEAYA has solved the crystal structures for each of its MAT2A, Pol Theta and Werner Helicase programs, enabling structure-based drug design, and has demonstrated in vivo proof of concept in relevant animal models for its MAT2A and Pol Theta programs.... More
